News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
874,316 Results
Type
Article (88242)
Company Profile (812)
Press Release (785241)
Multimedia
Podcasts (211)
Webinars (32)
Section
Business (233369)
Career Advice (4152)
Deals (39900)
Drug Delivery (160)
Drug Development (91495)
Employer Resources (205)
FDA (18455)
Job Trends (17445)
News (398187)
Policy (39999)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3025)
Academic (2)
Accelerated approval (41)
Adcomms (37)
Allergies (167)
Alliances (56982)
ALS (197)
Alzheimer's disease (1843)
Antibody-drug conjugate (ADC) (387)
Approvals (18653)
Artificial intelligence (695)
Autoimmune disease (216)
Automation (49)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (213)
Biotechnology (486)
Bladder cancer (179)
Brain cancer (70)
Breast cancer (709)
Cancer (5431)
Cardiovascular disease (481)
Career advice (3580)
Career pathing (44)
CAR-T (321)
CDC (68)
Celiac Disease (2)
Cell therapy (886)
Cervical cancer (42)
Clinical research (77563)
Collaboration (1998)
Company closure (6)
Compensation (1262)
Complete response letters (88)
COVID-19 (3008)
CRISPR (110)
C-suite (995)
Cystic fibrosis (157)
Data (6847)
Decentralized trials (2)
Denatured (78)
Depression (170)
Diabetes (567)
Diagnostics (7354)
Digital health (55)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (340)
Drug pricing (232)
Drug shortages (36)
Duchenne muscular dystrophy (275)
Earnings (100919)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (136062)
Executive appointments (1086)
FDA (21876)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (26)
Funding (1672)
Gene editing (236)
Generative AI (72)
Gene therapy (734)
GLP-1 (1182)
Government (5489)
Grass and pollen (8)
Guidances (390)
Healthcare (20992)
HIV (77)
Huntington's disease (57)
IgA nephropathy (92)
Immunology and inflammation (312)
Immuno-oncology (81)
Indications (140)
Infectious disease (3337)
Inflammatory bowel disease (220)
Inflation Reduction Act (17)
Influenza (135)
Intellectual property (273)
Interviews (817)
IPO (17973)
IRA (61)
Job creations (5203)
Job search strategy (2868)
JPM (73)
Kidney cancer (20)
Labor market (101)
Layoffs (665)
Leadership (44)
Legal (10168)
Liver cancer (102)
Longevity (25)
Lung cancer (722)
Lymphoma (401)
Machine learning (49)
Management (66)
Manufacturing (961)
MASH (189)
Medical device (15110)
Medtech (15184)
Mergers & acquisitions (23063)
Metabolic disorders (1524)
mRNA (209)
Multiple sclerosis (181)
NASH (23)
Neurodegenerative disease (400)
Neuropsychiatric disorders (110)
Neuroscience (3302)
Neurotech (1)
NextGen: Class of 2026 (7712)
Non-profit (5127)
Now hiring (72)
Obesity (746)
Opinion (351)
Ovarian cancer (178)
Pain (238)
Pancreatic cancer (256)
Parkinson's disease (333)
Partnered (39)
Patents (559)
Patient recruitment (574)
Peanut (65)
People (67241)
Pharmaceutical (139)
Pharmacy benefit managers (34)
Phase 1 (23963)
Phase 2 (33659)
Phase 3 (25356)
Pipeline (6462)
Policy (365)
Postmarket research (3554)
Preclinical (10745)
Press Release (72)
Prostate cancer (277)
Psychedelics (61)
Radiopharmaceuticals (319)
Rare diseases (1053)
Real estate (7445)
Recruiting (81)
Regulatory (29448)
Reports (69)
Research institute (2749)
Resumes & cover letters (653)
Rett syndrome (32)
RNA editing (21)
RSV (91)
Schizophrenia (167)
Series A (283)
Series B (207)
Service/supplier (30)
Sickle cell disease (110)
Special edition (29)
Spinal muscular atrophy (181)
Sponsored (49)
Startups (4342)
State (2)
Stomach cancer (21)
Supply chain (123)
Tariffs (101)
The Weekly (130)
Vaccines (1200)
Venture capital (104)
Weight loss (508)
Women's health (109)
Worklife (23)
Date
Today (123)
Last 7 days (658)
Last 30 days (3299)
Last 365 days (32805)
2026 (6644)
2025 (33227)
2024 (38127)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (95)
Alaska (7)
Arizona (359)
Arkansas (15)
Asia (51740)
Australia (9092)
California (12381)
Canada (3520)
China (1254)
Colorado (523)
Connecticut (545)
Delaware (370)
Europe (119120)
Florida (1845)
Georgia (401)
Hawaii (4)
Idaho (68)
Illinois (1039)
India (83)
Indiana (582)
Iowa (24)
Japan (478)
Kansas (135)
Kentucky (49)
Louisiana (38)
Maine (85)
Maryland (1540)
Massachusetts (9107)
Michigan (381)
Minnesota (699)
Mississippi (7)
Missouri (150)
Montana (37)
Nebraska (30)
Nevada (138)
New Hampshire (89)
New Jersey (3327)
New Mexico (33)
New York (3264)
North Carolina (1704)
North Dakota (10)
Northern California (5994)
Ohio (381)
Oklahoma (23)
Oregon (54)
Pennsylvania (2465)
Puerto Rico (25)
Rhode Island (52)
South America (1666)
South Carolina (73)
South Dakota (1)
Southern California (4809)
Tennessee (196)
Texas (1959)
United States (44581)
Utah (373)
Vermont (1)
Virginia (315)
Washington D.C. (88)
Washington State (1024)
West Virginia (4)
Wisconsin (140)
Wyoming (2)
There are 874,316 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rosalind Franklin University Doubles Helix 51 Incubator Fueling the next wave of bioinnovation: Helix 51 scales up as regional launchpad
March 12, 2026
·
1 min read
Press Releases
Bachem Reports Strong Sales Growth and Sustained High Profitability
March 12, 2026
·
5 min read
Press Releases
BioGene Therapeutics Inc. Appoints Raj S. Pruthi, MD, MHA, FACS, as Director
March 12, 2026
·
9 min read
Press Releases
Omios Biologics Announces Collaboration with City of Hope to Evaluate Next-Generation Oncolytic Virus Platform in Solid Tumors
March 12, 2026
·
1 min read
Events
AACR Oncology Industry Partnering Event
Join researchers and industry partners—from major pharmaceutical companies and small-mid-size biotech companies—to share early oncology pipelines and innovation strategies for drug development and presents analysts and investors with new partnership and licensing opportunities to advance these concepts.
March 12, 2026
Rare disease
Why Industry Is Questioning FDA’s Data-Sharing Push in Cell and Gene Therapy
After the FDA’s first-ever public listening meeting on data-sharing in the cell and gene therapy space, new draft guidance aims to standardize the practice. But recent decisions call into question whether shared evidence and prior knowledge will accelerate development in rare diseases.
March 12, 2026
·
5 min read
·
Ana Mulero
Earnings
Novo Holdings’ Assets Fell 34% in 2025 As Its Namesake Drugmaker Struggled
Total assets under management for Novo Holdings, Novo Nordisk’s controlling shareholder, fell by more than one-third last year. The report caps off a tumultuous year for the Novo group of companies.
March 12, 2026
·
1 min read
·
Annalee Armstrong
Layoff Tracker
Vistagen, Evotec, Reckitt Benckiser Downsize, Collectively Affecting Hundreds
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
March 12, 2026
·
35 min read
·
BioSpace Editorial Staff
Weight loss
Lilly Flags ‘Concerning’ Impurities in Compounded Tirzepatide
Combining tirzepatide with vitamin B12, a common additive in compounded versions of the drug, yields an impurity that could alter the drug’s toxicity profile and pose safety risks to patients, the company said in an open letter.
March 12, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Atara Biotherapeutics Provides Regulatory Update on Tabelecleucel - March 12, 2026
March 12, 2026
·
3 min read
1 of 87,432
Next
